From: Accuracy of SCORTEN in predicting mortality in toxic epidermal necrolysis
Number of patients | East Center of Burns Treatment and Reconstructive Surgery |
---|---|
24 | |
Female/Male (%) | 13/11 (54.17/45.83) |
Mean/median age | 50.25/58.00 [range 14–82, SD 19.86] |
Mean/median % TBSA | 69.24/75.60 [range 30–96, SD 25.54] |
History of neoplasm (%) | 5 (20.83) |
Mean/median day of subission | 2.92/3.00 [range 1–4, SD 1.10] |
Mean/median days of hospitalization | 20.83/14.00 [range 4–55, SD 15.42] |
Mean/median IVIG | 181.25/200.00 [range 30–480, SD 103.61] |
Mean/median | 10.52/11.00 [range 2–21, SD 5.07] |
Number of plasmaphereses | |
Mean/median UREA | 54.98/51.00 [range 17–133, SD 28.96] |
Mean/median HCO3 | 27.32/25.70 [range 17.30–35.60, SD 5.51] |
Mean/median GLUCOSE | 129.46/124.50 [range 80–230, SD 28.84] |
Mean/median HR | 99.75/99.00 [range 65–155, SD 21.15] |
Mortality | 3 (12.50) |
Mean/median SCORTEN | 3.29/3.00 [range 1–7, SD 1.27] |
Mean/median estimated death risk | 41.93/35.30 [range 3.20–90, SD 23.60] |